Regeneron stock last at USD 792.19, down 1.20 percent in New York trading
Published on 09/25/2026 at 19:32 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Regeneron stock was last at USD 792.19 on Nasdaq at 12:57:36 p.m. EDT on September 25, 2026, down 1.20 percent or USD 9.63. The stock lagged the S&P 500 by 1.27 percentage points, with the index up 0.07 percent at the same time. Regeneron has scheduled its third-quarter results for October 30.
The September 25, 2026 session in figures
Regeneron Pharmaceuticals, Inc. (ISIN US75886F1075) opened at USD 784.85 in New York trading on September 25, 2026. The shares stood at USD 792.19 at 12:57:36 p.m. EDT, a gain of USD 7.34 from the opening level. The stock's reported intraday change was negative 1.20 percent, equal to USD 9.63. The quoted level was 7.81 percent below the 52-week high of USD 859.34 and 46.43 percent above the 52-week low of USD 541.00.
Regeneron's reported price remained below the September 25 opening level despite the stock's earlier move through USD 784.85. The 12:57:36 p.m. EDT quote placed the shares USD 67.15 below their 52-week high. The same price stood USD 251.19 above the 52-week low. The session figures were recorded during regular Nasdaq trading rather than after-hours trading.
Results date and analyst action shape the background
Regeneron announced on September 24 that it will publish third-quarter 2026 results before the U.S. market opens on October 30, followed by an 8:30 a.m. ET conference call, as Regeneron Pharmaceuticals announced. The scheduled release gives the next results date a defined time before the October trading session. The company announcement did not provide a new financial figure in the release. The stock was down 1.20 percent at the reported intraday reading.
Wall Street Zen upgraded Regeneron from buy to strong-buy in a report dated September 20, as MarketBeat reported. The report cited a 50-day moving average of USD 766.83 and a 200-day moving average of USD 720.73. The rating action came within the five trading sessions through September 25. The reported target range also included a 12-month high of USD 859.34.
U.S. indexes and biotechnology trading on September 25, 2026
The S&P 500 stood at 7,711.19, up 0.07 percent, at 12:57 p.m. EDT on September 25, 2026. The Nasdaq Composite was at 26,950.59, up 0.05 percent at the same time. The Dow Jones Industrial Average was at 51,369.33, down 0.28 percent. Regeneron's 1.20 percent decline therefore underperformed both the S&P 500 and Nasdaq Composite by more than one percentage point.
The Nasdaq Composite's 0.05 percent advance was 1.25 percentage points above Regeneron's move. The S&P 500's 0.07 percent gain was 1.27 percentage points above the stock's performance. Regeneron's reported price remained 7.81 percent below USD 859.34, the cited 52-week high. The next scheduled company event is the October 30 results release at 8:30 a.m. ET.
